Workshop Author: Belinda Seto, Ph.D.; Deputy Director; National Institute of Biomedical Imaging and Bioengineering

Slide 1: Outline Why is this so fun and rewarding NIBIB funding opportunities Grant writing resources

Slide 2: Why is this so fun and rewarding

Slide 3: NIBIB funding opportunities The NIH Mission NIH is the steward of medical and behavioral research for the nation. Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability.

NIH Mission An agency of the Department of Health and Human Services, the NIH is the Federal focal point for health research. The NIH ICs (27 Separate Institutes and Centers) Different missions and priorities Different budgets Different ways of deciding which grants to fund

Slide 4: NIBIB Mission To improve human health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical, engineering, and computer sciences with the life sciences to advance basic research and medical care.

NIBIB Mission National Institute of Biomedical Imaging and Bioengineering

Slide 5: Current NIBIB Grant Portfolio Areas Imaging Agents and Molecular Probes Image Displays Image Guided Therapies and Interventions Image Perception Image Processing Magnetic, Biomagnetic and Bioelectric Devices Magnetic Resonance Imaging and Spectroscopy Nuclear Medicine Optical Imaging and Spectroscopy Ultrasound and Acoustics X ray, Electron and Ion Beam Biosensors Biomaterials Biomechanics Biomedical Informatics Computational Biology Drug and Gene Delivery Systems Lab-on-a-chip Technologies Medical Devices and Implant Science Nanotechnology Rehabilitation Engineering Surgical Tools and Techniques Telemedicine Tissue Engineering

Slide 6: How is NIBIB different? Design- and needs-driven research, as well as hypothesis-driven Focus on enabling technologies with broad applications to multiple diseases or biological processes Multi-disciplinary and collaborative research Inter-agency and inter-institute activities

Slide 7: NIBIB-HHMI Interfaces Initiative (Phase I) Reduce existing barriers to interdisciplinary graduate education: Develop integrated courses, laboratory experiences, and other education mechanisms for trainees from different scientific backgrounds Promote academic and administrative institutional change that facilitates interdisciplinary graduate study Produce set of ‘best practices’ on how to modify existing academic and administrative structures to facilitate interdisciplinary education

Slide 8: Program Focus NJIT/Rutgers/NJMS – Neuroscience JHU - Nanotechnology UCI – Systems Biology (Molecular-Population) UCSD – Systems Biology (Molecular-Organismal) UPenn - Imaging Informatics Brandeis – Systems Biology (Molecular-Population) CMU/UPitt – Imaging Informatics, Structural Biology UChicago – Biocomplexity (Molecular-Population) UCSF – Systems Biology (Molecular-Cellular) UNM – Biocomplexity (Molecular-Population)

Slide 9: Interfaces Initiative Transition Plan Phase I (3+ years) January, 2005 – Program Announcement November, 2005 – Phase I awards Phase II (5 years) June, 2008 - Receipt date September/October, 2008 - Scientific review January, 2009 – Advisory Council review March/April, 2009 – First Awards

Slide 10: Interfaces Initiative (Phase II) Relationship to Strategic Plan: This initiative will support the NIBIB commitment to interdisciplinary research training by providing student support for new institutional training programs designed to reduce existing barriers to interdisciplinary graduate education. Initiative Response: We expect all 10 of the funded Phase I programs to respond to this initiative. We also anticipate that other interdisciplinary training programs, including new programs and programs that applied for but did not receive Phase I funding, to respond to this initiative. We will not permit our existing T32 training programs to respond to this initiative.

Slide 11: Training-related Awards Training-related Awards Mechanism Awards Total Diversity Supplements 23 $1,268,281 Residency Supplements 8 $1,057,507 Re-entry Supplements --- --- R13 Conference Support 14 $210,000 R15 AREA Awards 5 $1,031,833 Loan Repayment 2 $147,556

Slide 12: Inter-agency Partnerships Inter-agency Partnerships Mechanism Awards Trainees Total NIBIB-HHMI Interfaces Initiative 10 ~100 FY2009 Bioengineering and Bioinformatics Summer Insts. (BBSI) 13 ~175 $784,500 Biomed. Eng. Summer Intern Program (BESIP) --- 17 $115,000 NIH-NIST Fellowship Program --- 4 $338,250 Meyerhoff Fellowship --- 5 $300,000

Slide 13: Grant Writing

NIH Peer Review Process

Slide 14: General NIH Review Criteria Significance Approach Innovation Investigator Environment

Slide 15: What reviewers REALLY want to know The significance of what you are proposing That your approach is appropriate That you can do what you propose

Slide 16: Why Is Good Grant Writing So Important? Reviewers are very busy people Committees review many grants Reviewers have a very limited amount of time to make the case for your grant Even in times of plenty, there are more meritorious applications than can be paid

Slide 17: Resources NIBIB Scientific Program Staff Christine Kelley kelleyc@mail.nih.gov Brenda Korte kortebr@mail.nih.gov Grace Peng penggr@mail.nih.gov Zohara Cohen cohenz@mail.nih.gov Rosemarie Hunzinger hunzinr@mail.nih.gov Alan McLaughlin mclaugal@mail.nih.gov John Haller hallerj@mail.nih.gov Hector Lopez lopezh@mail.nih.gov Yantian Zhang yzhang1@mail.nih.gov John Anderson andersj@mail.nih.gov Richard Baird bairdr@mail.nih.gov

Inside the NIH Grant Review Process Mock Study Section Video http://www.csr.nih.gov/video/video.asp

NIBIB Website

CRISP Website

CRISP Web Query

Slide 18: Conclusion “To give away money is an easy matter and in any man’s power. But to decide to whom to give it, and how much and when, and for what purpose and how, is neither in every man’s power nor an easy matter. Hence, it is that such excellence is rare, praiseworthy, and noble.” ---Aristotle